Collaboration will bring next generation orchestration and modular automation to scientists worldwide

INDIANAPOLIS – (January 29, 2026) – Beckman Coulter Life Sciences and Automata today announced a strategic partnership that integrates Beckman Coulter Life Sciences liquid handling, genomic and cell analysis technologies with Automata’s AI-ready automation platform to enable faster, more consistent and more scalable experimentation for research organizations. The collaboration brings together Beckman Coulter Life Sciences, a global leader in laboratory automation and innovation and a subsidiary of Danaher Corporation, and Automata, a London-based lab automation company modernizing how R&D laboratories design, execute and scale scientific workflows.

The partnership is part of a larger investment in which Danaher Ventures will participate in Automata’s Series C funding round and join the company’s board of directors, strengthening alignment and long-term support for joint innovation.

“This partnership reflects our relentless focus on empowering scientists to translate ideas into impact faster,” said Joe Fox, President of Beckman Coulter Life Sciences. “Agentic AI is poised to transform the way wet-lab screening studies are performed. Partnering with Automata allows us to combine our trusted life science tools with cutting-edge automation infrastructure that makes the lab of the future accessible today.”

The goal of the collaboration is to allow customers to generate more data, more reliably for greater insights, faster innovation and increased trust in findings by:

• Improving workflow reliability, data integrity and autonomous operation for AI-ready research environments.
• Enabling scalable, connected lab of the future designs that rapidly configure, deploy and expand modular work cells tuned to specific applications.
• Empowering scientists with AI-driven tools and simulated science for maximized throughput and efficiency.

The partnership integrates Beckman Coulter Life Sciences instruments into Automata’s LINQ automation ecosystem—a modular, scalable platform composed of intelligent robotics, unified scheduling software and an agile workflow design environment. LINQ’s cloud-native orchestration engine enables laboratories to standardize and automate multistep experimental processes, delivering structured, high-quality datasets that are essential for AI-driven discovery and analysis.

About Beckman Coulter Life Sciences

Time is the most critical facet in the laboratory today: time to get life-saving therapies to patients faster; reclaiming time by automating tedious manual workflows; and saving time otherwise spent addressing erroneous or complex results.

At Beckman Coulter Life Sciences, a Danaher company, we are partners in time. We accelerate answers to critical questions through the power of efficiency, saving hours from some workflows and delivering reliable results in centrifugation, flow cytometry, genomic solutions, particle analysis/counters, and liquid handlers.

We develop innovations for scientists by scientists, with many of our 3,300+ global colleagues coming from the laboratory with a deep understanding of today’s challenges and complexities. We’re passionate about translating science in partnership with our customers, and our customizable, accessible and sustainable solutions empower them with intuitive workflow efficiencies.

Time and again customers put their trust in us, with 400,000+ of our built-to-last products currently delivering results in labs worldwide – all backed by our dependable service and application experts offering educational insights and tailored support.

It’s all part of our time-tested approach since 1935 to bring meaningful innovations at the speed of life—and we’re just beginning. Working together, let’s advance human health for a better tomorrow!

Get to know us by clicking here and by following us on LinkedIn.

About Danaher

Danaher is a leading global life sciences and diagnostics innovator, committed to accelerating the power of science and technology to improve human health. Our businesses partner closely with customers to solve many of the most important health challenges impacting patients around the world. Danaher's advanced science and technology - and proven ability to innovate - help enable faster, more accurate diagnoses and help reduce the time and cost needed to sustainably discover, develop and deliver life-changing therapies. Focused on scientific excellence, innovation and continuous improvement, our approximately 63,000 associates worldwide help ensure that Danaher is improving quality of life for billions of people today, while setting the foundation for a healthier, more sustainable tomorrow. Explore more at www.danaher.com.

Beckman Coulter, the stylized logo, and the Beckman Coulter product and service marks mentioned herein are trademarks or registered trademarks of Beckman Coulter, Inc. in the United States and other countries.